Mori, Hiroyoshi
Braumann, Ryan
Torii, Sho
Jinnouchi, Hiroyuki
Harari, Emanuel
Kutys, Robert
Romero, Maria
Virmani, Renu
Finn, Aloke
Article History
Received: 19 July 2017
Accepted: 28 November 2017
First Online: 5 December 2017
Compliance with ethical standards
:
: The study was sponsored by CVPath Institute, a non-profit organization dedicated cardiovascular research. There was no industry involvement in the design, conduct, financial support, or analysis of this study.
: CVPath Institute has research Grants from Abbott Vascular, Atrium Medical, Boston Scientific, Biosensors International, Cordis-Johnson&Johnson, Medtronic CardioVascular, OrbusNeich Medical and Terumo Corporation. H. M has received honorarium from Abbott Vascular Japan, Goodman and Terumo Corporation. S. T has received honorarium from Abbott Vascular Japan, Terumo Corporation and SUNRISE lab. R. V has speaking engagements with Merck; receives honoraria from Abbott Vascular, Boston Scientific, Lutonix, Medtronic and Terumo Corporation and is a consultant for 480 Biomedical, Abbott Vascular, Medtronic and W. L. Gore. A. V. Finn has sponsored research agreements with Boston Scientific and Medtronic CardioVascular and is an advisory board member to Medtronic CardioVascular. The other authors report no conflict.